PRESYNAPTIC EFFECT OF BETA-ADRENOCEPTOR ANTAGONISTS ON NORADRENERGIC NEURONS

被引:45
作者
WEINSTOCK, M [1 ]
机构
[1] TEL AVIV UNIV, SACKLER SCH MED, DEPT PHYSIOL & PHARMACOL, RAMAT AVIV, ISRAEL
关键词
D O I
10.1016/0024-3205(76)90089-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Besides their blocking effect on .beta.-adrenoceptors, propranolol and some related drugs also reduced the effect of sympathetic nerve stimulation by inhibiting noradrenaline (norepinephrine, NA) release. The mechanism of this presynaptic effect is unclear. The present data on the subject and the evidence in favor of the suggested mechanisms were discussed. Some .beta.-adrenoceptor antagonists could mask the presynaptic inhibitory effect, particularly in vivo (cat nictitating membrane and dog hindlimb). The possible relevance of a presynaptic action to the antiarrhythmic effects and other therapeutic actions of these drugs were discussed. In vitro studies were performed with rabbit and guinea-pig vas deferens and atria. The ideal .beta.-adrenoceptor antagonist to use to demonstrate an inhibitory effect on NA release in vivo is apparently one which lacks membrane stabilizing properties and therefore would also be unlikely to inhibit reuptake of the release NA into sympathetic neurons. The compound should have a relatively weak depressant effect on cardiac output so that it does not cause reflex stimulation of the sympathoadrenal system and peripheral vasoconstriction.
引用
收藏
页码:1453 / 1466
页数:14
相关论文
共 106 条
[1]   INHIBITORY EFFECT OF PROPRANOLOL ON VASOCONSTRICTOR RESPONSE TO SYMPATHETIC NERVE STIMULATION [J].
ABLAD, B ;
EK, L ;
JOHANSSO.B ;
WALDECK, B .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (08) :627-&
[2]   COMBINED TREATMENT OF PARKINSONIAN TREMOR WITH PROPRANOLOL AND LEVODOPA [J].
ABRAMSKY, O ;
CARMON, A ;
LAVY, S .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1971, 14 (04) :491-&
[3]   POSSIBLE ROLE OF A BETA-ADRENOCEPTOR IN REGULATION OF NORADRENALINE RELEASE BY NERVE-STIMULATION THROUGH A POSITIVE FEEDBACK MECHANISM [J].
ADLERGRASCHINSK.E ;
LANGER, SZ .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (01) :43-50
[4]  
ARAMENDIA P, 1976, J PHARMACOL EXP THER, V155, P259
[5]   FURTHER STUDIES WITH PROPRANOLOL IN PSYCHOTIC PATIENTS - RELATION TO INITIAL PSYCHIATRIC STATE, URINARY CATECHOLAMINES AND 3-METHOXY-4-HYDROXYPHENYLGLYCOL EXCRETION [J].
ATSMON, A ;
BLUM, I ;
LATZ, A ;
STEINER, M ;
WIJSENBEEK, H .
PSYCHOPHARMACOLOGIA, 1972, 27 (03) :249-+
[6]  
ATSMON A, 1971, PSYCHIAT NEUROL NEUR, V74, P251
[7]  
AURIOL B, 1972, NOUV PRESSE MED, V1, P1439
[8]  
BAKKE OM, 1974, BRIT J PHARMACOL, V51, pP148
[9]   BIOLOGICAL PROPERTIES OF OPTICAL ISOMERS OF PROPRANOLOL AND THEIR EFFECTS ON CARDIAC ARRHYTHMIAS [J].
BARRETT, AM ;
CULLUM, VA .
BRITISH JOURNAL OF PHARMACOLOGY, 1968, 34 (01) :43-+
[10]   ADRENERGIC NEURON BLOCKING PROPERTIES OF (+/-)-PROPRANOLOL AND (+)-PROPRANOLOL [J].
BARRETT, AM ;
NUNN, B .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 (11) :806-+